You just read:

FDA Approves Label Update for ZYTIGA® to Include Statistically Significant Overall Survival Results in Chemotherapy-Naive Men with Metastatic Castration-Resistant Prostate Cancer

News provided by

Janssen Research & Development, LLC

Mar 30, 2015, 08:00 ET